Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs provides a comprehensive selection of high-quality anti-HLA-A2 recombinant antibodies, specifically designed to meet the rigorous demands of modern research and therapeutic applications. Each antibody in our collection is meticulously engineered using our advanced recombinant technology, ensuring unparalleled specificity and stability. These antibodies are essential tools for researchers focused on the intricate mechanisms of immune response, particularly in the context of targeted cancer therapy. With excellent binding affinity and functional performance, our anti-HLA-A2 antibodies empower scientists to explore innovative treatments and enhance the understanding of immune evasion in tumors.
HLA-A2 is a vital human leukocyte antigen (HLA) due to its high occurrence in the population and its essential role in presenting antigens to T cells, which is crucial for initiating immune responses. Its function is especially significant in cancer immunotherapy, where HLA-A2 serves as a target for developing cancer vaccines and T-cell therapies. These strategies attempt to activate the immune system to detect and destroy tumor cells containing HLA-A2-bound tumor-specific antigens, improving therapeutic efficacy and opening the path for individualized cancer treatment.
HLA-A; HLA class I histocompatibility antigen, A-1 alpha chain; HLA class I histocompatibility antigen; Major histocompatibility complex, class I, A; HLAA; Antigen-presenting molecule; leukocyte antigen class I-A.
HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-A alleles have been described.
Creative Biolabs provides highly customized anti-HLA-A2 recombinant antibody products for sophisticated research and therapeutic applications. These antibodies are specially designed to target the HLA-A2 antigen, which is an important component of the immune response and a major participant in many disorders, including cancer. Our recombinant antibodies have great specificity and affinity, delivering accurate and consistent findings in your research. These products, which are manufactured using cutting-edge technology, are appropriate for a wide range of applications, including flow cytometry, immunohistochemistry, ELISA, etc. Creative Biolabs' strict quality control techniques provide the greatest purity and performance, allowing researchers to investigate immunological pathways and create novel treatment solutions.
Table 1. Featured anti-HLA-A2 recombinant antibody products at Creative Biolabs.
Cat. No. | Product Name | Target Species | Host Species | Applications |
FAMAB-0158JF | Human Anti-HLA-A2 Recombinant Antibody (clone 3PF12) | Human | Human IgG | WB, FC, Inhib |
FAMAB-0167YC | Mouse Anti-HLA-A2 Recombinant Antibody (clone G1) | Human | Mouse IgG | ELISA, FC, IHC, Cyt |
FAMAB-0156JF | Human Anti-HLA-A2 Recombinant Antibody (clone 3PB2) | Human | Human IgG | WB, ELISA, IHC, FuncS |
FAMAB-0157JF | Human Anti-HLA-A2 Recombinant Antibody (clone 3PC4) | Human | Human IgG | WB, FC |
Creative Biolabs provides a wide selection of anti-HLA-A2 recombinant antibodies that are precisely produced to the highest quality standards. Our cutting-edge facilities and experienced scientists are dedicated to designing each antibody precisely, guaranteeing that it targets HLA-A2 with extraordinary precision. We ensure that our antibodies have great specificity, strong binding affinity, and perfect optical properties, making them suitable for a wide range of research applications.
Creative Biolabs offers a reliable range of high-quality anti-HLA-A2 antibodies, expertly engineered using advanced genetic techniques to ensure optimal performance in various research applications.
Featured Anti-HLA-A2 Recombinant Antibody Production Platforms
Fig.1 Milligram-scale anti-HLA-A2 recombinant antibody production.
Fig.2 Gram-scale anti-HLA-A2 recombinant antibody production.
Creative Biolabs offers an extensive selection of premium anti-HLA-A2 recombinant antibodies, available in multiple formats to cater to the diverse needs of researchers worldwide.
Fig.3 Full-length anti-HLA-A2 recombinant antibody production and modalities.
Table 2. Public drug targeting HLA-A2.
Company | Research Phase | Classification | Condition |
Beijing CorreGene Biotechnology (Originator) | Phase I |
Cancer Immunotherapy TCR-Modified T Cells |
Cancer, anus Cancer, cervix Cancer, head and neck Cancer, solid tumor |
Charite Universitaetsmedizin Berlin (Originator) | Preclinical | TCR-Modified T Cells | Transplant rejection |
Chinese Academy of Sciences (Originator) Guangzhou Institutes Biomedicine Health (Originator) |
Preclinical |
Cancer Immunotherapy TCR-Modified T Cells |
Cancer, liver (hepatocellular carcinoma, HBV-related) |
Qingdao University (QU) (Originator) University of California, Davis (Originator) |
Preclinical |
Oligopeptides, less than 10 AA Peptide Vaccines |
Cancer |
Qingdao University (QU) (Originator) University of California, Davis (Originator) |
Preclinical |
Oligopeptides, less than 10 AA Peptide Vaccines |
Cancer |
Qingdao University (QU) University of California, Davis |
Preclinical |
Oligopeptides, less than 10 AA Peptide Vaccines |
Cancer |
University of Tokyo (Originator) | Preclinical | Murine Monoclonal Antibodies | Graft-versus-host disease |
University of Texas System (Originator) | Preclinical |
Cancer Immunotherapy Murine Monoclonal Antibodies TCR-Like Antibodies |
Acute myeloid leukemia |
Third Affiliated Hosp Sun Yat-sen Univ (Originator) | Biological Testing |
Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) (Second-Generation CAR) Regulatory T Cells (Treg) |
Autoimmune disease Transplant rejection |
Hadasit (Originator) | Biological Testing |
Cancer Immunotherapy TCR-Modified T Cells |
Melanoma |
(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)
Creative Biolabs is a prominent biological research service firm, specializing in offering high-quality laboratory supplies and solutions to researchers throughout the globe. In our expanding product line, the Anti-HLA-A2 recombinant antibody series is a highlight. These antibodies are targeted at HLA-A2 antigens, have high specificity and affinity, and are widely used in research in immunology, oncology, and related fields. If you are interested in our anti-HLA-A2 recombinant antibody products, please get in touch with us without hesitation.